Role of HDAC6 inhibition in sepsis‑induced acute respiratory distress syndrome (Review)
- Authors:
- Qinghua Zhang
- Yan Wang
- Danhua Qu
- Jinyan Yu
- Junling Yang
-
Affiliations: Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China - Published online on: February 25, 2021 https://doi.org/10.3892/etm.2021.9866
- Article Number: 422
This article is mentioned in:
Abstract
 |
|
Ashbaugh DG, Bigelow DB, Petty TL and Levine BE: Acute respiratory distress in adults. Lancet. 2:319–323. 1967.PubMed/NCBI View Article : Google Scholar | |
|
Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, et al: The Berlin definition of ARDS: An expanded rationale, justification, and supplementary material. Intensive Care Med. 38:1573–1582. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, et al: LUNG SAFE Investigators; ESICM Trials Group: Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 315:788–800. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, et al: Canadian Critical Care Trials Group: Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 364:1293–1304. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Han S and Mallampalli RK: The acute respiratory distress syndrome: From mechanism to translation. J Immunol. 194:855–860. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Griffiths MJD, McAuley DF, Perkins GD, Barrett N, Blackwood B, Boyle A, Chee N, Connolly B, Dark P, Finney S, et al: Guidelines on the management of acute respiratory distress syndrome. BMJ Open Respir Res. 6(e000420)2019.PubMed/NCBI View Article : Google Scholar | |
|
Walkey AJ, Del Sorbo L, Hodgson CL, Adhikari NKJ, Wunsch H, Meade MO, Uleryk E, Hess D, Talmor DS, Thompson BT, et al: Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 14 (Suppl 4):S297–S303. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Hodgson CL, Cooper DJ, Arabi Y, King V, Bersten A, Bihari S, Brickell K, Davies A, Fahey C, Fraser J, et al: Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP). A Phase II, Multicenter Randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 200:1363–1372. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT and Ancukiewicz M: National Heart, Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 354:1671–1684. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Peck TJ and Hibbert KA: Recent advances in the understanding and management of ARDS. F1000 Res. 8(8)2019.PubMed/NCBI View Article : Google Scholar | |
|
Villar J, Ferrando C, Martínez D, Ambrós A, Muñoz T, Soler JA, Aguilar G, Alba F, González-Higueras E, Conesa LA, et al: dexamethasone in ARDS network: Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial. Lancet Respir Med. 8:267–276. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ and Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med. 353:1685–1693. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Ito K, Caramori G, Lim S, Oates T, Chung KF, Barnes PJ and Adcock IM: Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med. 166:392–396. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Sadoul K, Boyault C, Pabion M and Khochbin S: Regulation of protein turnover by acetyltransferases and deacetylases. Biochimie. 90:306–312. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Dekker FJ and Haisma HJ: Histone acetyl transferases as emerging drug targets. Drug Discov Today. 14:942–948. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Zou H, Wu Y, Navre M and Sang BC: Characterization of the two catalytic domains in histone deacetylase 6. Biochem Biophys Res Commun. 341:45–50. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Gilquin B, Khochbin S and Matthias P: Two catalytic domains are required for protein deacetylation. J Biol Chem. 281:2401–2404. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Schäfer S, Saunders L, Eliseeva E, Velena A, Jung M, Schwienhorst A, Strasser A, Dickmanns A, Ficner R and Schlimme S: Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). Bioorg Med Chem. 16:2011–2033. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, Olashaw N, Parsons JT, Yang XJ, Dent SR, et al: HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell. 27:197–213. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Bali P, Pranpat M, Bradner J, Balasis M, Fiskus W, Guo F, Rocha K, Kumaraswamy S, Boyapalle S, Atadja P, et al: Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: A novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem. 280:26729–26734. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Parab S, Shetty O, Gaonkar R, Balasinor N, Khole V and Parte P: Correction to: HDAC6 deacetylates alpha tubulin in sperm and modulates sperm motility in Holtzman rat. Cell Tissue Res. 371(375)2018.PubMed/NCBI View Article : Google Scholar | |
|
Wang XX, Wan RZ and Liu ZP: Recent advances in the discovery of potent and selective HDAC6 inhibitors. Eur J Med Chem. 143:1406–1418. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Jia YJ, Liu ZB, Wang WG, Sun CB, Wei P, Yang YL, You MJ, Yu BH, Li XQ and Zhou XY: HDAC6 regulates microRNA-27b that suppresses proliferation, promotes apoptosis and target MET in diffuse large B-cell lymphoma. Leukemia. 32:703–711. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Vogl DT, Raje N, Jagannath S, Richardson P, Hari P, Orlowski R, Supko JG, Tamang D, Yang M, Jones SS, et al: Ricolinostat, the first selective histone deacetylase 6 inhibitor, in combination with bortezomib and dexamethasone for relapsed or refractory multiple myeloma. Clin Cancer Res. 23:3307–3315. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Yee AJ, Bensinger WI, Supko JG, Voorhees PM, Berdeja JG, Richardson PG, Libby EN, Wallace EE, Birrer NE, Burke JN, et al: Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A multicentre phase 1b trial. Lancet Oncol. 17:1569–1578. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Tu Y, Hershman DL, Bhalla K, Fiskus W, Pellegrino CM, Andreopoulou E, Makower D, Kalinsky K, Fehn K, Fineberg S, et al: A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Breast Cancer Res Treat. 146:145–152. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Halili MA, Andrews MR, Labzin LI, Schroder K, Matthias G, Cao C, Lovelace E, Reid RC, Le GT, Hume DA, et al: Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS. J Leukoc Biol. 87:1103–1114. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Estenssoro E and Dubin A: Acute respiratory distress syndrome. Medicina (B Aires). 76:235–241. 2016.PubMed/NCBI(In Spanish). | |
|
Kasznica J, Helmann M, Collins JP and Akhtar R: Bilateral Ebstein-like anomaly with atrial septal defect. Jpn Heart J. 36:119–125. 1995.PubMed/NCBI View Article : Google Scholar | |
|
Fu P, Murley JS, Grdina DJ, Birukova AA and Birukov KG: Induction of cellular antioxidant defense by amifostine improves ventilator-induced lung injury. Crit Care Med. 39:2711–2721. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Kratzer E, Tian Y, Sarich N, Wu T, Meliton A, Leff A and Birukova AA: Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilization. Am J Respir Cell Mol Biol. 47:688–697. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Zhao B, Gao W, Gao X, Leng Y, Liu M, Hou J and Wu Y: Sulforaphane attenuates acute lung injury by inhibiting oxidative stress via Nrf2/HO-1 pathway in a rat sepsis model. Int J Clin Exp Pathol. 10:9021–9028. 2017.PubMed/NCBI | |
|
Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM and Garcia JG: Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med. 169:1245–1251. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Kong J, Zhu X, Shi Y, Liu T, Chen Y, Bhan I, Zhao Q, Thadhani R and Li YC: VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system. Mol Endocrinol. 27:2116–2125. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Thangavel J, Malik AB, Elias HK, Rajasingh S, Simpson AD, Sundivakkam PK, Vogel SM, Xuan YT, Dawn B and Rajasingh J: Combinatorial therapy with acetylation and methylation modifiers attenuates lung vascular hyperpermeability in endotoxemia-induced mouse inflammatory lung injury. Am J Pathol. 184:2237–2249. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Xu Q, Liu J, Wang Z, Guo X, Zhou G, Liu Y, Huang Q and Su L: Heat stress-induced disruption of endothelial barrier function is via PAR1 signaling and suppressed by Xuebijing injection. PLoS One. 10(e0118057)2015.PubMed/NCBI View Article : Google Scholar | |
|
Joshi AD, Barabutis N, Birmpas C, Dimitropoulou C, Thangjam G, Cherian-Shaw M, Dennison J and Catravas JD: Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function. Am J Physiol Lung Cell Mol Physiol. 309:L1410–L1419. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Borgas D, Chambers E, Newton J, Ko J, Rivera S, Rounds S and Lu Q: Cigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6. Am J Respir Cell Mol Biol. 54:683–696. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Yu J, Ma Z, Shetty S, Ma M and Fu J: Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema. Am J Physiol Lung Cell Mol Physiol. 311:L39–L47. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Karki P, Ke Y, Tian Y, Ohmura T, Sitikov A, Sarich N, Montgomery CP and Birukova AA: Staphylococcus aureus-induced endothelial permeability and inflammation are mediated by microtubule destabilization. J Biol Chem. 294:3369–3384. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Rosenjack J, Hodges CA, Darrah RJ and Kelley TJ: HDAC6 depletion improves cystic fibrosis mouse airway responses to bacterial challenge. Sci Rep. 9(10282)2019.PubMed/NCBI View Article : Google Scholar | |
|
Deng Q, Zhao T, Pan B, Dennahy IS, Duan X, Williams AM, Liu B, Lin N, Bhatti UF, Chen E, et al: Protective Effect of Tubastatin A in CLP-Induced Lethal Sepsis. Inflammation. 41:2101–2109. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Li Y, Zhao T, Liu B, Halaweish I, Mazitschek R, Duan X and Alam HB: Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model. J Trauma Acute Care Surg. 78:378–385. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Yu J, Ma M, Ma Z and Fu J: HDAC6 inhibition prevents TNF-α-induced caspase 3 activation in lung endothelial cell and maintains cell-cell junctions. Oncotarget. 7:54714–54722. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Cheng X, Liu Z, Liu B, Zhao T, Li Y and Alam HB: Selective histone deacetylase 6 inhibition prolongs survival in a lethal two-hit model. J Surg Res. 197:39–44. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Yoo J, Kim SJ, Son D, Seo H, Baek SY, Maeng CY, Lee C, Kim IS, Jung YH, Lee SM, et al: Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity. Eur J Med Chem. 116:126–135. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Moreno-Gonzalo O, Mayor F Jr and Sánchez-Madrid F: HDAC6 at Crossroads of Infection and Innate Immunity. Trends Immunol. 39:591–595. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhao T, Li Y, Liu B, Pan B, Cheng X, Georgoff P and Alam HB: Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model. J Trauma Acute Care Surg. 80:34–40; discussion 40-41. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Yan B, Xie S, Liu Y, Liu W, Li D, Liu M, Luo HR and Zhou J: Histone deacetylase 6 modulates macrophage infiltration during inflammation. Theranostics. 8:2927–2938. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhang WB, Yang F, Wang Y, Jiao FZ, Zhang HY, Wang LW and Gong ZJ: Inhibition of HDAC6 attenuates LPS-induced inflammation in macrophages by regulating oxidative stress and suppressing the TLR4-MAPK/NF-κB pathways. Biomed Pharmacother. 117(109166)2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhao T, Li Y, Bronson RT, Liu B, Velmahos GC and Alam HB: Selective histone deacetylase-6 inhibition attenuates stress responses and prevents immune organ atrophy in a lethal septic model. Surgery. 156:235–242. 2014.PubMed/NCBI View Article : Google Scholar | |
|
González-Mariscal L, Tapia R and Chamorro D: Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta. 1778:729–756. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Di Liddo R, Valente S, Taurone S, Zwergel C, Marrocco B, Turchetta R, Conconi MT, Scarpa C, Bertalot T, Schrenk S, et al: Histone deacetylase inhibitors restore IL-10 expression in lipopolysaccharide-induced cell inflammation and reduce IL-1β and IL-6 production in breast silicone implant in C57BL/6J wild-type murine model. Autoimmunity: Jan 20, 2016 (Epub ahead of print). | |
|
Youn GS, Lee KW, Choi SY and Park J: Overexpression of HDAC6 induces pro-inflammatory responses by regulating ROS-MAPK-NF-κB/AP-1 signaling pathways in macrophages. Free Radic Biol Med. 97:14–23. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Youn GS, Ju SM, Choi SY and Park J: HDAC6 mediates HIV-1 tat-induced proinflammatory responses by regulating MAPK-NF-kappaB/AP-1 pathways in astrocytes. Glia. 63:1953–1965. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Jo H, Jang HY, Youn GS, Kim D, Lee CY, Jang JH, Choi SY, Jun JG and Park J: Hindsiipropane B alleviates HIV-1 Tat-induced inflammatory responses by suppressing HDAC6-NADPH oxidase-ROS axis in astrocytes. BMB Rep. 51:394–399. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhang WB, Zhang HY, Jiao FZ, Wang LW, Zhang H and Gong ZJ: Histone deacetylase 6 inhibitor ACY-1215 protects against experimental acute liver failure by regulating the TLR4-MAPK/NF-κB pathway. Biomed Pharmacother. 97:818–824. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Liu L, Zhou X, Shetty S, Hou G, Wang Q and Fu J: HDAC6 inhibition blocks inflammatory signaling and caspase-1 activation in LPS-induced acute lung injury. Toxicol Appl Pharmacol. 370:178–183. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wang J, Zhao L, Wei Z, Zhang X, Wang Y, Li F, Fu Y and Liu B: Inhibition of histone deacetylase reduces lipopolysaccharide-induced-inflammation in primary mammary epithelial cells by regulating ROS-NF-кB signaling pathways. Int Immunopharmacol. 56:230–234. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Hiscott J: Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18:483–490. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Nusinzon I and Horvath CM: Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation. Mol Cell Biol. 26:3106–3113. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Chattopadhyay S, Fensterl V, Zhang Y, Veleeparambil M, Wetzel JL and Sen GC: Inhibition of viral pathogenesis and promotion of the septic shock response to bacterial infection by IRF-3 are regulated by the acetylation and phosphorylation of its coactivators. MBio. 4(4)2013.PubMed/NCBI View Article : Google Scholar | |
|
Trani M and Dejana E: New insights in the control of vascular permeability: Vascular endothelial-cadherin and other players. Curr Opin Hematol. 22:267–272. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Rodrigues SF and Granger DN: Blood cells and endothelial barrier function. Tissue Barriers. 3(e978720)2015.PubMed/NCBI View Article : Google Scholar | |
|
Nam HJ, Kang JK, Kim SK, Ahn KJ, Seok H, Park SJ, Chang JS, Pothoulakis C, Lamont JT and Kim H: Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation. J Biol Chem. 285:32888–32896. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Saito S, Lasky JA, Guo W, Nguyen H, Mai A, Danchuk S, Sullivan DE and Shan B: Pharmacological inhibition of HDAC6 attenuates endothelial barrier dysfunction induced by thrombin. Biochem Biophys Res Commun. 408:630–634. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Wang F, Zheng L, Yi Y, Yang Z, Qiu Q, Wang X, Yan W, Bai P, Yang J, Li D, et al: SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting Microtubules. Mol Cancer Ther. 17:763–775. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Majolée J, Pronk MCA, Jim KK, van Bezu JSM, van der Sar AM, Hordijk PL and Kovačević I: CSN5 inhibition triggers inflammatory signaling and Rho/ROCK-dependent loss of endothelial integrity. Sci Rep. 9(8131)2019.PubMed/NCBI View Article : Google Scholar | |
|
Croisé P, Estay-Ahumada C, Gasman S and Ory S: Rho GTPases, phosphoinositides, and actin: A tripartite framework for efficient vesicular trafficking. Small GTPases. 5(e29469)2014.PubMed/NCBI View Article : Google Scholar | |
|
Joshi AD, Dimitropoulou C, Thangjam G, Snead C, Feldman S, Barabutis N, Fulton D, Hou Y, Kumar S, Patel V, et al: Heat shock protein 90 inhibitors prevent LPS-induced endothelial barrier dysfunction by disrupting RhoA signaling. Am J Respir Cell Mol Biol. 50:170–179. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Valenta T, Hausmann G and Basler K: The many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Winer IS, Bommer GT, Gonik N and Fearon ER: Lysine residues Lys-19 and Lys-49 of beta-catenin regulate its levels and function in T cell factor transcriptional activation and neoplastic transformation. J Biol Chem. 281:26181–26187. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Sauteur L, Krudewig A, Herwig L, Ehrenfeuchter N, Lenard A, Affolter M and Belting HG: Cdh5/VE-cadherin promotes endothelial cell interface elongation via cortical actin polymerization during angiogenic sprouting. Cell Rep. 9:504–513. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Dejana E and Vestweber D: The role of VE-cadherin in vascular morphogenesis and permeability control. Prog Mol Biol Transl Sci. 116:119–144. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Huber AH and Weis WI: The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell. 105:391–402. 2001.PubMed/NCBI View Article : Google Scholar | |
|
D'Alessandro M, Hnia K, Gache V, Koch C, Gavriilidis C, Rodriguez D, Nicot AS, Romero NB, Schwab Y, Gomes E, et al: Amphiphysin 2 orchestrates nucleus positioning and shape by linking the nuclear envelope to the actin and microtubule cytoskeleton. Dev Cell. 35:186–198. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Coles CH and Bradke F: Coordinating neuronal actin-microtubule dynamics. Curr Biol. 25:R677–R691. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF and Yao TP: HDAC6 is a microtubule-associated deacetylase. Nature. 417:455–458. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, Seigneurin-Berny D, Osada H, Komatsu Y, Nishino N, Khochbin S, et al: In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J. 21:6820–6831. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Shivanna M and Srinivas SP: Microtubule stabilization opposes the (TNF-alpha)-induced loss in the barrier integrity of corneal endothelium. Exp Eye Res. 89:950–959. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Bogatcheva NV and Verin AD: The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res. 76:202–207. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Iaconelli J, Huang JH, Berkovitch SS, Chattopadhyay S, Mazitschek R, Schreiber SL, Haggarty SJ and Karmacharya R: HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of β-catenin in human iPSC-derived neuronal cells. ACS Chem Biol. 10:883–890. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Matsuda N, Takano Y, Kageyama S, Hatakeyama N, Shakunaga K, Kitajima I, Yamazaki M and Hattori Y: Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock. Cardiovasc Res. 76:132–140. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Sawant DA, Tharakan B, Tobin RP, Reilly J, Hunter FA, Newell MK, Smythe WR and Childs EW: Microvascular endothelial cell hyperpermeability induced by endogenous caspase 3 activator staurosporine. J Trauma Acute Care Surg. 74:516–523. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Lopez-Ramirez MA, Fischer R, Torres-Badillo CC, Davies HA, Logan K, Pfizenmaier K, Male DK, Sharrack B and Romero IA: Role of caspases in cytokine-induced barrier breakdown in human brain endothelial cells. J Immunol. 189:3130–3139. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Zehendner CM, Librizzi L, de Curtis M, Kuhlmann CR and Luhmann HJ: Caspase-3 contributes to ZO-1 and Cl-5 tight-junction disruption in rapid anoxic neurovascular unit damage. PLoS One. 6(e16760)2011.PubMed/NCBI View Article : Google Scholar | |
|
Leyk J, Daly C, Janssen-Bienhold U, Kennedy BN and Richter-Landsberg C: HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness. Cell Death Dis. 8(e3028)2017.PubMed/NCBI View Article : Google Scholar | |
|
Wang X, Tang X, Zhou Z and Huang Q: Histone deacetylase 6 inhibitor enhances resistance to Mycobacterium tuberculosis infection through innate and adaptive immunity in mice. Pathog Dis. 76(76)2018.PubMed/NCBI View Article : Google Scholar | |
|
Wang H, Ling L, Ai L and Bai L: HDAC6 inhibition induces the failure of mouse early embryonic development. J Cell Physiol. 234:8752–8759. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Choi YJ, Kang MH, Hong K and Kim JH: Tubastatin A inhibits HDAC and Sirtuin activity rather than being a HDAC6-specific inhibitor in mouse oocytes. Aging (Albany NY). 11:1759–1777. 2019.PubMed/NCBI View Article : Google Scholar |
